March 14-15 | ExCel, London
Join Asphalion at the Advanced Therapies Congress!! The event will be held in London and our experts Chris Mann and Oriol Penon will be available at BOOTH #74 to present you Asphalion and all the solutions we can provide you with, as well as to discuss all your regulatory needs.
ATMPs complexity requires specific development approaches and regulatory adaptations to overcome the challenging environment involving ATMPs. Asphalion’s team has specific expertise and broad scientific background in regulatory strategy, CMC and clinical development in ATMPs.
Asphalion can elaborate all regulatory, non-clinical, clinical and CMC documentation required during development, registration and lifecycle of ATMPs. In addition, strategic inputs can be given from the very beginning for segmentation/niche indication, conditional approval/fast track, orphan drug designations, preclinical and clinical development plans with minimum time-to-market.
If you want to schedule a meeting, you can send an email at: firstname.lastname@example.org
Looking forward to meet you in London!